Pharmaxis Ltd
ASX:PXS.AX
0.028 (AUD) • At close December 6, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.765 | 7.426 | 6.68 | 7.027 | 5.676 | 7.282 | 13.286 | 14.335 | 57.741 | 5.036 | 3.237 | 1.466 | 1.202 | 1.17 | 1.025 | 0.527 | 2.357 | 0.008 | 0.001 | 0 | 0.041 |
| Cost of Revenue
| 2.706 | 9.953 | 5.935 | 7.797 | 1.689 | 0 | 0 | 0 | 0 | 1.858 | 1.141 | 0.522 | 0.342 | 0.307 | 0.153 | 0.129 | 0.049 | 0.002 | 0 | 0 | 0 |
| Gross Profit
| 3.059 | -2.527 | 0.745 | -0.77 | 3.987 | 7.282 | 13.286 | 14.335 | 57.741 | 3.178 | 2.096 | 0.944 | 0.86 | 0.863 | 0.872 | 0.398 | 2.308 | 0.006 | 0.001 | 0 | 0.041 |
| Gross Profit Ratio
| 0.531 | -0.34 | 0.112 | -0.11 | 0.702 | 1 | 1 | 1 | 1 | 0.631 | 0.648 | 0.644 | 0.715 | 0.738 | 0.851 | 0.755 | 0.979 | 0.75 | 1 | 0 | 1 |
| Reseach & Development Expenses
| 8.713 | 7.224 | 4.767 | 6.341 | 8.662 | 0 | 0 | 0 | 0 | 17.702 | 23.862 | 29.222 | 34.632 | 35.14 | 29.308 | 19.996 | 23.84 | 16.978 | 9.155 | 6.047 | 1.79 |
| General & Administrative Expenses
| 15.523 | 14.083 | 14.871 | 14.465 | 15.493 | 15.12 | 14.158 | 13.907 | 19.02 | 8.268 | 6.03 | 5.387 | 5.171 | 9.715 | 5.8 | 5.231 | 4.666 | 4.386 | 3.105 | 2.182 | 0.981 |
| Selling & Marketing Expenses
| 0.305 | 0.755 | 1.469 | 1.346 | 1.136 | 1.163 | 1.061 | 1.101 | 1.962 | 9.522 | 13.893 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 15.828 | 14.838 | 16.34 | 15.811 | 16.629 | 16.283 | 15.219 | 15.008 | 20.982 | 17.79 | 19.923 | 5.387 | 5.171 | 9.715 | 5.8 | 5.231 | 4.666 | 4.386 | 3.105 | 2.182 | 0.981 |
| Other Expenses
| 14.034 | 7.22 | 17.991 | 5 | 5.155 | 32.571 | 4.793 | 2.629 | 0.785 | 3.715 | 5.675 | 3.739 | 0.173 | 0.274 | 0.093 | 1.576 | 2.152 | 1.299 | 1.172 | 1.153 | 0.978 |
| Operating Expenses
| 28.347 | 30.194 | 27.322 | 28.494 | 31.56 | 33.629 | 36.505 | 36.918 | 43.104 | 58.411 | 54.186 | 50.586 | 53.992 | 53.533 | 42.575 | 30.808 | 32.685 | 24.107 | 13.733 | 8.718 | 3.027 |
| Operating Income
| -11.864 | -14.438 | -3.696 | -15.879 | -19.389 | 6.983 | -17.723 | -18.741 | 16.143 | -35.63 | -38.9 | -37.95 | -44.85 | -45.44 | -34.998 | -30.41 | -30.377 | -24.101 | -13.732 | -8.718 | -2.986 |
| Operating Income Ratio
| -2.058 | -1.944 | -0.553 | -2.26 | -3.416 | 0.959 | -1.334 | -1.307 | 0.28 | -7.075 | -12.017 | -25.887 | -37.313 | -38.838 | -34.144 | -57.704 | -12.888 | -3,012.625 | -27,464.256 | 0 | -72.043 |
| Total Other Income Expenses Net
| 14.034 | 7.22 | 17.991 | 5 | 5.155 | 32.571 | 4.793 | 2.455 | 0.454 | -5.068 | 3.985 | 3.739 | 0.173 | 0.274 | 0.093 | 1.576 | 2.152 | 1.299 | 1.172 | 1.153 | 0.978 |
| Income Before Tax
| -11.36 | -1.936 | -2.97 | -13.943 | -20.058 | 6.42 | -18.346 | -16.456 | 18.508 | -51.715 | -43.535 | -38.718 | -45.709 | -46.294 | -35.12 | -20.408 | -24.16 | -17.728 | -10.232 | -6.001 | -1.468 |
| Income Before Tax Ratio
| -1.971 | -0.261 | -0.445 | -1.984 | -3.534 | 0.882 | -1.381 | -1.148 | 0.321 | -10.269 | -13.449 | -26.411 | -38.027 | -39.568 | -34.263 | -38.725 | -10.25 | -2,216 | -20,464.714 | 0 | -35.419 |
| Income Tax Expense
| 14.257 | -6.236 | 18.36 | -2.524 | 5.393 | -0.008 | 5.416 | 0.007 | 0.042 | 0.103 | 0.002 | -0.074 | 0.049 | 0.051 | 0.051 | 0.032 | 0.019 | 0.005 | -10.232 | -6.001 | -1.468 |
| Net Income
| -11.36 | -1.936 | -2.97 | -13.943 | -20.058 | 6.428 | -18.346 | -16.463 | 18.466 | -51.818 | -43.537 | -38.644 | -45.758 | -46.345 | -35.171 | -20.44 | -24.179 | -17.733 | -10.232 | -6.001 | -1.468 |
| Net Income Ratio
| -1.971 | -0.261 | -0.445 | -1.984 | -3.534 | 0.883 | -1.381 | -1.148 | 0.32 | -10.29 | -13.45 | -26.36 | -38.068 | -39.611 | -34.313 | -38.786 | -10.258 | -2,216.625 | -20,464.714 | 0 | -35.419 |
| EPS
| -0.017 | -0.003 | -0.007 | -0.035 | -0.053 | 0.02 | -0.058 | -0.052 | 0.059 | -0.17 | -0.14 | -0.14 | -0.19 | -0.2 | -0.17 | -0.1 | -0.13 | -0.11 | -0.079 | -0.063 | -0.014 |
| EPS Diluted
| -0.017 | -0.003 | -0.007 | -0.035 | -0.053 | 0.02 | -0.058 | -0.052 | 0.059 | -0.17 | -0.14 | -0.14 | -0.19 | -0.2 | -0.17 | -0.1 | -0.13 | -0.11 | -0.079 | -0.063 | -0.014 |
| EBITDA
| -9.289 | -12.154 | 0.551 | -18.231 | -17.201 | 10.333 | -14.664 | -15.713 | 19.788 | -21.477 | -34.08 | -33.046 | -39.824 | -42.419 | -33.733 | -29.386 | -29.438 | -23.309 | -13.106 | -8.229 | -2.73 |
| EBITDA Ratio
| -1.611 | -1.637 | 0.082 | -2.594 | -3.03 | 1.419 | -1.104 | -1.096 | 0.343 | -4.265 | -10.528 | -22.542 | -33.131 | -36.256 | -32.91 | -55.761 | -12.49 | -2,913.625 | -26,211.994 | 0 | -65.872 |